• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

To those who quit Hepatitis C

Quote
Anonymous said:
The only real question is whether your reading skills, or your comprehension abilities are weaker.
Click to expand...

Challenge all of my colleagues to read the article! If we need RBV in genotype 1a to compete with Harnoni than we are F'ed!! As for my reading comprehension, I especially like the observation that Abbvie didn't correctly predict the 2014 HCV market! We shot behind the duck not in front of it! Time to boogie out of this place!
 




Anonymous said:
Challenge all of my colleagues to read the article! If we need RBV in genotype 1a to compete with Harnoni than we are F'ed!! As for my reading comprehension, I especially like the observation that Abbvie didn't correctly predict the 2014 HCV market! We shot behind the duck not in front of it! Time to boogie out of this place!
Click to expand...

Finally. Buh Bye
 








It's approval day for us. Feels great! How about you losers? Still waiting for yours. Don't worry BMS won't do layoffs yet, well not until they figure out your drug will be left without a musical chair.
 








Anonymous said:
A big FU, Moron! Once we are on the market, Abbvie will kick Gilead, JNJ, and Merck butts!
Click to expand...

OMG such arrogance! Exactly what are you going to use to kick butts? Clinical superiority? NO, Pill count? NO, BID? NO, Drug-drug interactions? NO, HCV market experience? NO, Pipeline? NO, Need to use ribavirin? NO, Price? Maybe but for a short time, competition will just match the price. Now tell me how y'all going kick butt?!?!?!?!?!? Quit drinking the Kool Aid and wise up!!
 








Anonymous said:
OMG such arrogance! Exactly what are you going to use to kick butts? Clinical superiority? NO, Pill count? NO, BID? NO, Drug-drug interactions? NO, HCV market experience? NO, Pipeline? NO, Need to use ribavirin? NO, Price? Maybe but for a short time, competition will just match the price. Now tell me how y'all going kick butt?!?!?!?!?!? Quit drinking the Kool Aid and wise up!!
Click to expand...

We have a can do attitude. Obviously you don't. Let's see who wins the positive or negative attitude.
 












Anonymous said:
Why does my MSL get to go the Liver Meeting and basically get a paid vacation and I can't? This situation is TOTALLY UNFAIR!!!
Click to expand...

I scanned the abstracts, lectures, etc. for the Liver Meeting and 90% of the HCV therapy data presented are Gilead's! WTH!!! My MSL has called with an update for our district! WTF!
 




Anonymous said:
I scanned the abstracts, lectures, etc. for the Liver Meeting and 90% of the HCV therapy data presented are Gilead's! WTH!!! My MSL has called with an update for our district! WTF!
Click to expand...

Guieald's stock is up over $3 in early trading! Reason: HCV data at Liver Meeting!!! Our MSL doesn't tell us anything and I heard from confidential sources that our exhibit at the Liver Meeting is an embarrassment!! We also sponsored a map of Boston for attendees - what a WASTE of $s!! Ricky needs to corral the HCV management team and confine them to the outhouse!! Talk about lack of motivation for the sales force!
 




Anonymous said:
Guieald's stock is up over $3 in early trading! Reason: HCV data at Liver Meeting!!! Our MSL doesn't tell us anything and I heard from confidential sources that our exhibit at the Liver Meeting is an embarrassment!! We also sponsored a map of Boston for attendees - what a WASTE of $s!! Ricky needs to corral the HCV management team and confine them to the outhouse!! Talk about lack of motivation for the sales force!
Click to expand...

Hey Negative Nelly: Quit posting your trash! We need to have confidence in our science, clinical results, and management expertise!! If you don't like being on our team than just get the H out!
 




Having seen your booth, the "uniforms" that everyone is wearing and the fact that your at the back of the hall, it is clear Abbvie is in for a rocky ride.

Sincerly

Another Hepatitis Company
 








Anonymous said:
Stay on your own Board! What do you mean by uniform?! Where was your booth located?
Click to expand...

Did I strike a nerve?! Uniforms as in men wearing white dress shirts and women wearing white shirts and pinky sweaters, all within the confines of your aseptic, all white two story exhibit.
Need not worry where mine was, just lets say it was closer to the main entrance......good day my friend
 




I have read highlights from Boston meeting of studies from both Gilead and from BMS. Merck showed some struggles with shortened therapy. Abbvie? Nothing. That can't be a good thing.
 




Anonymous said:
Did I strike a nerve?! Uniforms as in men wearing white dress shirts and women wearing white shirts and pinky sweaters, all within the confines of your aseptic, all white two story exhibit.
Need not worry where mine was, just lets say it was closer to the main entrance......good day my friend
Click to expand...

Location is OK. On the way to the posters and just off the Sheraton entrance. No worries. Enjoy boston.
 




Data presented equates to competitive DISADVANTAGE - - - we are snakebit!! HIV/HCV & non-cirrhotic transplant => need 12 WEEKS of therapy with RIBAVIRIN!!! Why are all of our studies so conservative and don't give us anything to sell against Gilead and Merck!!!
 




Just read the Gilead press releases on Harvoni and it is really good. I believe we are sunk even before we launch our HCV ship. Marketing gimmicks will not sway this market! I feel really depressed. Can someone brighten my mood? Desperate seeking a good hug!
 




Top Bottom
Back
Quote